ResMed’s intelligent non-invasive ventilation solutions suitable for COPD

COPD

Today, on World COPD Day, we are excited to share the results of the HOT-HMV trial presented at ERS, which show that HMV added to HOT can reduce by 51% the likelihood of readmissions to hospital or death over one year in hypercapnic COPD patients following an acute exacerbation of COPD.1 There are new prospects for better treatment of COPD—and better lives for patients.

copd

Evidence has shown improved outcomes when non-invasive ventilation is added to a COPD treatment program.1-3

ResMed offers you intelligent non-invasive ventilation solutions that can help you tailor treatment to the unique and changing needs of your patients. From ventilators and masks to oxygen options and accessories, ResMed’s solutions work together to help patients breathe easier as they manage their condition.

Our solutions are “intelligent” because they allow you to choose the most appropriate product combination to suit your individual COPD patient’s needs, and provide automatically-adjusting therapy as their condition progresses, for even more personalisation.

You can do this with:

  1. Our comprehensive range of ventilators with patented technologies for excellence in NIV and synchrony
  2. Our range of comfortable masks that help patients better accept non-invasive ventilation
  3. Our data management solutions for long-term care  
Lumis_series_article_sta

Picturing better outcomes with ResMed

Products

Lumis150_VPAP_ST-A (1)

Personalised non-invasive ventilation made easy

Devices_Astral_150_heroimage1

Portable life support ventilators that enrich life

AcuCare_F1-0_hero_image (1)

Comfortable masks to fit a wide range of patients

ResScan-heroimage3

PC-based clinical analysis and data management software

Devices_Astral_150_heroimage

Our ventilators feature various options to deliver and monitor supplemental oxygen

Explore

References

1

Koehnlein T et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease – A prospective, multicentre, randomized, controlled cpnical trial. Lancet Respir Med. 2014;2:698-705.

2

Ram F et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004;CD004104.

3

Galp JA et al. Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD, Respir Med. 2014;108(5):722-8.


* World Health Organization. “Chronic respiratory diseases: Burden of COPD” Who.int. http://www.who.int/gho/pubpcations/world_health_statistics/en/ (accessed November 9, 2015)